PLOS
open access
CC BY 4.0
Validation of the Bronchiectasis Severity Index in alpha-1 antitrypsin deficiency
Bronchiectasis is increasingly recognised in patients with alpha-1 antitrypsin deficiency (AATD), yet prognostic tools validated in general bronchiectasis populations have not been specifically evaluated in this group. The Bronchiectasis Severity Index (BSI) is a widely used multidimensional score
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The PROspective German NOn-CF bronchiectaSIS Patient Registry#835914
- An interpretable prognostic model for early unfavorable outcomes after bronchiectasis surgery.#1097880
- Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis#871117
- A clinical scoring system to predict the development of bronchopulmonary dysplasia#954813
- Evaluation of Medical and Nursing Management for Bronchiectasis#1162851
Record · ID 1001739
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive